Physicians’ Reasons for Failing to Deliver Effective Breast Cancer Care
A Framework for Underuse
Dados Bibliográficos
| ID | 9101029 |
|---|---|
| Autores | Nina A Bickell (0000-0003-1102-8677, Icahn School of Medicine at Mount Sinai, autor correspondente), Mary Dee McEvoy |
| Ano | 2003 |
| Volume | 41 |
| Fascículo | 3 |
| Páginas | 442-446 |
| Data de publicação | 2003-03-01 |
| Peer Reviewed | Sim |
| Open Access | Não |
| Tipo | ARTICLE |
| Periódico | Medical Care (JOURNAL) |
| Identificadores do periódico | ISSN: 0025-7079 • E-ISSN: 1537-1948 |
| Editora | Ovid Technologies (Wolters Kluwer Health) (PUBLISHER) |
| DOI | 10.1097/01.mlr.0000052978.49993.27 |
| PMID | 12618647 |
| OpenAlex | W2324949050 |
| Idioma | EN |
| Citações recebidas | 3 |
| Referências citadas | 20 |
OBJECTIVE: Despite numerous randomized trials showing the health benefits of systemic and local therapies for early-stage breast cancer, underuse of these therapies remains a significant quality problem. Little is known about causes of underuse of effective cancer treatments. We sought to understand these causes to design effective interventions to improve care. RESEARCH DESIGN: To identify categories of causes of underuse, semistructured interviews were performed with physicians of breast cancer patients who did not receive effective adjuvant care in the 4 years following surgery. Underuse was defined by expert consensus based on evidence-based guidelines. SUBJECTS: Surgeons (n = 13) of all early-stage breast cancer cases who underwent surgical treatment at a tertiary care hospital and had underuse of local or systemic adjuvant therapies. RESULTS: Of all the 275 women with early-stage breast cancer, there were 44 episodes of underuse of effective therapies (16%). In 48% of cases, physicians thought treatment should occur but the treatment failed to take place (32%) or the patient refused (16%). For the other 52% of cases, physicians thought treatment should not occur because evidence did not support treatment in clinical circumstances such as older age (32%), a good prognosis based on tumor size or histology (11%), a second primary breast cancer (5%), or because of comorbidities (5%). All surgeons were aware of the benefits of adjuvant treatments. CONCLUSIONS: Causes of underuse can be identified and categorized. Using these categories, a framework of causes of underuse was constructed and interventions targeting the specific causes to improve the quality of care are suggested
Breast cancer · Cancer · Clinical trial · Family medicine · Health care · Intensive care medicine · MEDLINE · Psychological intervention · Randomized controlled trial · Stage (stratigraphy) · Breast Cancer Treatment Studies · Economic and Financial Impacts of Cancer · Healthcare cost, quality, practices · Internal Medicine · Medicine · Nursing · Surgery
| Obras citantes distintas | 3 |
|---|---|
| Citações por ano | 0,13 |
| Intervalo de citações | 2003 - 2016 (14) |
| Velocidade de citação | historical |
| Altamente citado | Não |
| Tipos de citação | Neutras: 2 |